Escolar Documentos
Profissional Documentos
Cultura Documentos
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Sr.
#
1.
2.
3.
4.
5.
6.
7.
8.
9.
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
OBSERVATIONS
RECOMMENDATION
REQUIREMENTS of cGMP
Poor
(No)
Inadequate
Satisfactory
(Yes)
Excellent
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
Page 2 of 20
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Sr.
#
Audit Date:_____________
REQUIREMENTS of cGMP
Auditor(s) 1)_______________2)_______________3)______________
Poor
(No)
OBSERVATIONS
Satisfactor
Inadequate
y
(Yes)
Recommendation
Excellent
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
13.
14.
15.
16.
17.
18.
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Sr.
#
Audit Date:_____________
REQUIREMENTS of cGMP
Auditor(s) 1)_______________2)_______________3)______________
Poor
(No)
OBSERVATIONS
Satisfactory
Inadequate
(Yes)
RECOMMENDATION
Excellent
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
cross-contamination?
Is there written procedure for sanitization of
22. pipes used for conveying distilled, de-ionized
or other water pipes describing the limits and
action to be taken for sanitization?
Is written program available indicating the
following cleaning procedures for the premises
and the equipment used in the production of
drug, namely:
a) Cleaning requirements applicable to all
production areas of plant.
b) Cleaning requirements applicable to all
processing equipment.
c) Cleaning intervals.
23. d) Cleaning materials, their concentration and
equipment to be used.
e) Disposal procedures for waste materials and
debris.
f) Pest control measures.
g) Precautions required to prevent
contamination of drugs when rodenticides,
insecticides and fumigation agents are used.
h) Microbial and environmental monitoring
procedures and limits in areas where
susceptible products are manufactured.
Are initial and continuing training records
24.
available for all personnel regarding CGMP and
hygiene instructions?
Page 6 of 20
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Sr.
#
25.
26.
27.
28.
Audit Date:_____________
REQUIREMENTS of cGMP
Auditor(s) 1)_______________2)_______________3)______________
OBSERVATIONS
Poor
Satisfactory
Inadequate
(No)
(Yes)
RECOMMENDATION
Excellent
Page 7 of 20
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Sr.#
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
REQUIREMENTS of cGMP
Poor
(No)
OBSERVATIONS
Inadequate Satisfactory
(Yes)
Excellent
Recommendation
General
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
39.
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
fills?
Are all the clean room tools (e.g. spatulas, spanners, etc)
55. specifically used for those areas and regularly sterilized?
56. Are all the environmental results trended?
Are interventions into the class 100 environmental recorded during
57. productions?
Media Fills
What percentage of routine media fills have passed first time during
58. annually?
Is your media fill acceptance criteria based upon the 95%
59. confidence limit of finding 1/1000 contamination level?
Are your products and media filled units both incubated for 14
60. days?
Are media fills ready by personnel specifically trained and qualified
61. to detect growth?
62. Are contaminated media fill units fully speciated?
Were media fills performed at least twice per year for each aseptic
filling line annually covering a logical selection of pack
63. presentations (e.g. Ampoule size etc)?
Does someone observe and record activities during media fills such
64. as intervention?
Environmental Monitoring Program
Does the environmental monitoring program include a check of
65. disinfectants being used?
Is all environmental data considered as part of final QA release of
66. finished sterile product?
Is the routine environmental monitoring program based upon data
67. obtained during room qualification?
68. If the environmental test results exceed the action limit is it reported
Page 10 of 20
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
Is water for injection used for final rinse of component and product
contact equipment wash cycles?
Are all WFI points of used routinely monitored as part of the water
sampling program?
Does the WFI sampling technique replicate production use?
Is the system presents in water supply system to prevent the
microbial growth for example constant circulation of 90oC or at
temperature validated to keep microbial count of water within the
limit?
Sterilizers
88.
89.
90.
91.
92.
93.
94.
95.
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
96.
Sr.
#
97.
98.
99.
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
OBSERVATIONS
Poor
Satisfactory
Inadequate
Excellent
(No)
(Yes)
RECOMMENDATION
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
Sr.
#
REQUIREMENTS of cGMP
OBSERVATIONS
Poor
Satisfactory
Inadequate
Excellent
(No)
(Yes)
106.
107.
100.
101.
102.
103.
104.
105.
RECOMMENDATION
Page 14 of 20
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
periodically?
Sr.
#
108.
109.
110.
111.
112.
113.
114.
REQUIREMENTS of cGMP
OBSERVATIONS
Poor
(No)
Inadequate
Satisfactory
Excellent
(Yes)
RECOMMENDATION
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
116.
Sr.
#
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
OBSERVATIONS
REQUIREMENTS of cGMP
RECOMMENDATION
Poor
Satisfactory
Inadequate
Excellent
(No)
(Yes)
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
Page 17 of 20
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
Sr.
#
Audit Date:_____________
REQUIREMENTS of cGMP
Auditor(s) 1)_______________2)_______________3)______________
OBSERVATIONS
Poor
Inadequate
(No)
127.
128.
129.
Satisfactory
(Yes)
RECOMMENDATION
Excellent
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
130.
131.
132.
133.
134.
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
completion of production.
c) Initials of operator of different significant
steps of production and the person who
checked each of these operations.
d) Major equipment used.
e) In-process controls and the initials of the
person(s) carrying then out and results
obtained.
f) The amount of drug obtained at different
stages of manufacture.
g) Notes on special problems including details,
with signed authorization, for any deviation
from Master Formula.
Are the unused batch-coded packaging materials
destroyed and destruction recorded upon
completion of packaging operation?
Are finished products held in Quarantine until
release?
Are the checks on yield and re-conciliation of
quantities carried out to ensure that yield is
within limits? Whether yield deviations are
recorded and investigated or not?
Are all materials, bulk containers, equipments
and rooms are labeled and identified during
processing with and indication of material or
product being processed to indicate information
about material & processing stage?
Is the following clause of CGMP being followed
during packaging activity? Attention shall be
Page 19 of 20
SURGE LAB.
(PVT) LTD.
F-10-02 (A)
REV. NO.: 1
Issue Date:
19.10.2009
135.
136.
137.
138.
139.
Audit Date:_____________
Auditor(s) 1)_______________2)_______________3)______________
Page 20 of 20